CARMEN RAINES: Open Payments
NPI 1104241686 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 101 payments from 15 companies in 2025. Trend: 2023 $1,654 · 2024 $1,679 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $253 |
| PFIZER INC. | 14 | $244 |
| Novo Nordisk Inc | 9 | $202 |
| Lilly USA, LLC | 13 | $193 |
| Amgen Inc. | 12 | $189 |
| AstraZeneca Pharmaceuticals LP | 11 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $105 |
| GlaxoSmithKline, LLC. | 6 | $88 |
| Boston Scientific Corporation | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
Products named: MOUNJARO, EVENITY, FARXIGA, Kerendia, QULIPTA, Wegovy, NURTEC ODT, JARDIANCE.
Industry payments across MS — which companies pay providers there.
